Mass General Brigham Innovation
Somerville, Massachusettsmassgeneralbrigham.org
Overview
Mass General Brigham Innovation is the business development arm of Mass General Brigham, responsible for the worldwide commercial application of the discoveries made by Mass General Brigham's 80,000 employees . It coordinates industrial relationships and IP management across the Mass General Brigham healthcare system . The organization works with medical inventors, investors, entrepreneurs, and industry to shape the future of medicine . Innovation is responsible for industry collaborations, venture investing, licensing, company creation, technology marketing, open innovation alliances, and workforce development .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Violet Therapeutics | May 2026 | Seed | Co-investor |
| Nocion Therapeutics | Jan 2026 | Series B Extension | Co-investor |
| Affinia Therapeutics | Oct 2025 | Series C | Co-investor |
| Carta Healthcare | May 2025 | Series B Extension | Co-investor |
| Abcuro | Feb 2025 | Series C | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.